Drawing for AMGIVLY

USPTO serial 99507681

AMGIVLY

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
YONTEF, DAVID ERIC
Law office
TMO LAW OFFICE 100

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with AMGIVLY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kumiko Ide

Kumiko Ide WENDEROTH, LIND & PONACK, LLP1025 Connecticut Avenue NW, Suite 500Washington, DC 20036United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of cancerACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 18, 2026MAB1ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT—
Jun 18, 2026ABN1ABANDONMENT - EXPRESS MAILED—
Jun 17, 2026EXARTEAS EXPRESS ABANDONMENT RECEIVED—
May 21, 2026LOPRLETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN—
May 21, 2026LOPTLETTER OF PROTEST EVIDENCE FORWARDED—
Mar 27, 2026GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Mar 27, 2026GNSLLETTER OF SUSPENSION E-MAILED—
Mar 27, 2026CNSLSUSPENSION LETTER WRITTEN—
Mar 27, 2026AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Mar 26, 2026DOCKASSIGNED TO EXAMINER—
Dec 11, 2025TAEATEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED—
Dec 11, 2025PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Nov 20, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 20, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 20, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance